申请人:Daiichi Suntory Pharma Co., Ltd.
公开号:EP1437339A1
公开(公告)日:2004-07-14
A substituted benzoic acid derivative which is represented by the following formula (I) and has an NF-κB inhibiting action (in the formula, R3, R4 and R5 each independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon(s) or an alkoxy group having 1 to 6 carbon(s); R9 and R10 each independently represents a hydrogen atom, an alkyl group having 1 to 6 carbon(s) or an acyl group having 2 to 11 carbons); R2 represents an optionally-substituted aromatic hydrocarbon group or an optionally-substituted heterocyclic group; and X represents a carboxyl group which may be esterified or amidated).
or
由下式(I)表示并具有 NF-κB 抑制作用的取代苯甲酸衍生物(式中,R3、R4 和 R5 各自独立地代表氢原子、具有 1 至 6 个碳原子的烷基或具有 1 至 6 个碳原子的烷氧基;R9 和 R10 各自独立地代表氢原子、具有 1 至 6 个碳原子的烷基或具有 2 至 11 个碳原子的酰基);R2 代表任选取代的芳香烃基团或任选取代的杂环基团;X 代表可被酯化或酰胺化的羧基)。
或